Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
1,21 Although it is generally accepted that patients receiving ICIs and combination ICIs may experience irAEs affecting multiple organ sites, the exact incidence of concurrent or sequential irAEs in the same patient has not been reported in the kidney cancer population
doi:10.1016/j.juro.2009.02.121
Most healthcare professionals recommend using it for at least 16 weeks to determine its effectiveness
To construct a diploid homozygous strain expressing URA3 as the counter-selectable marker in the BY4743 background, first pGSH1 sequence (0585 bp upstream of the GSH1 ORF) and HS fragments for URA3 were amplified from yeast genomic DNA
US$ 28.81
US$ 20.70
US$ 28.50
US$ 25.41
US$ 25.33
